Trade Summary

4 days ago, Sandrock Alfred, serving as Pres, CEO at Voyager Therapeutics, Inc. (VYGR), sold 11,732 shares at $3.41 per share, for a total transaction value of $40,006.00. Following this transaction, Sandrock Alfred now holds 498,257 shares of VYGR.

This sale represents a 2.00% decrease in Sandrock Alfred's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, February 18, 2026 and publicly disclosed via SEC Form 4 filing on Friday, February 20, 2026, 2 days after the trade was made.

Voyager Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.